ATE150315T1 - N-methylierte zyklische undecapeptide enthaltende arzneimittelzubereitungen - Google Patents

N-methylierte zyklische undecapeptide enthaltende arzneimittelzubereitungen

Info

Publication number
ATE150315T1
ATE150315T1 AT93918877T AT93918877T ATE150315T1 AT E150315 T1 ATE150315 T1 AT E150315T1 AT 93918877 T AT93918877 T AT 93918877T AT 93918877 T AT93918877 T AT 93918877T AT E150315 T1 ATE150315 T1 AT E150315T1
Authority
AT
Austria
Prior art keywords
pct
weight parts
preparations containing
methylated cyclic
cyclic undecapeptides
Prior art date
Application number
AT93918877T
Other languages
English (en)
Inventor
Milan Stuchlik
Zdenek Pavelek
Lubos Markovic
Original Assignee
Galena As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galena As filed Critical Galena As
Application granted granted Critical
Publication of ATE150315T1 publication Critical patent/ATE150315T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT93918877T 1992-09-07 1993-09-03 N-methylierte zyklische undecapeptide enthaltende arzneimittelzubereitungen ATE150315T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS922770A CZ278863B6 (en) 1992-09-07 1992-09-07 Medicinal preparations with n-methylated cyclic undecapeptides

Publications (1)

Publication Number Publication Date
ATE150315T1 true ATE150315T1 (de) 1997-04-15

Family

ID=5365741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918877T ATE150315T1 (de) 1992-09-07 1993-09-03 N-methylierte zyklische undecapeptide enthaltende arzneimittelzubereitungen

Country Status (16)

Country Link
US (1) US5670478A (de)
EP (1) EP0659084B1 (de)
JP (1) JPH08501088A (de)
KR (1) KR100294569B1 (de)
AT (1) ATE150315T1 (de)
AU (1) AU4941493A (de)
CA (1) CA2142452C (de)
CZ (1) CZ278863B6 (de)
DE (1) DE69309078T2 (de)
DK (1) DK0659084T3 (de)
ES (1) ES2102052T3 (de)
GR (1) GR3023726T3 (de)
HU (1) HU221815B1 (de)
LV (1) LV11885B (de)
SK (1) SK278290B6 (de)
WO (1) WO1994005312A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077800C (zh) * 1993-07-01 2002-01-16 韩美药品工业株式会社 环孢菌素软胶囊组合物
ES2308955T5 (es) 1993-09-28 2012-04-03 R.P. Scherer Gmbh Fabricación de cápsulas de gelatina blanda
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
IL115742A (en) * 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
DE19825462C2 (de) * 1998-06-08 2001-03-08 Cognis Deutschland Gmbh Emulgatoren
PT1154759E (pt) 1998-12-30 2008-11-20 Dexcel Ltd Concentrado dispersível para administração de ciclosporina
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7034037B2 (en) * 2001-06-29 2006-04-25 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
US7030127B2 (en) * 2001-06-29 2006-04-18 Ethicon, Inc. Composition and medical devices utilizing bioabsorbable polymeric waxes
US6967234B2 (en) * 2002-12-18 2005-11-22 Ethicon, Inc. Alkyd-lactone copolymers for medical applications
US6960563B2 (en) * 2001-08-31 2005-11-01 Morton Grove Pharmaceuticals, Inc. Spontaneous emulsions containing cyclosporine
DK1436321T3 (da) 2001-10-19 2006-11-13 Isotechnika Inc Syntese af cyclosporinanaloger
US7005136B2 (en) 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
US7326426B2 (en) 2002-03-29 2008-02-05 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
US7368125B2 (en) * 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
US7026374B2 (en) * 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
US7101566B2 (en) * 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
US6872799B2 (en) * 2002-12-18 2005-03-29 Ethicon, Inc. Functionalized polymers for medical applications
US6866860B2 (en) 2002-12-19 2005-03-15 Ethicon, Inc. Cationic alkyd polyesters for medical applications
US20040120981A1 (en) * 2002-12-20 2004-06-24 Aruna Nathan Crosslinked alkyd polyesters for medical applications
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
US20060165641A1 (en) * 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
DE102010043787A1 (de) * 2010-11-11 2012-05-16 Evonik Degussa Gmbh Bindemittel für Holzwerkstoffe

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL158165B (nl) * 1973-05-15 1978-10-16 Amsterdam Chem Comb Werkwijze voor de bereiding van carbonzuuresters van lineaire alifatische suikeralcoholen.
CH589716A5 (en) * 1973-12-06 1977-07-15 Sandoz Ag Antibiotics S 7481-F-1 and 2 - prepd. from new strains of Cylindrocarbon or Trichoderma esp. useful as immunosuppressant
CH603790A5 (en) * 1974-10-21 1978-08-31 Sandoz Ag Antibiotics S 7481-F-1 and 2
CH636013A5 (en) * 1978-03-07 1983-05-13 Sandoz Ag More readily absorbable pharmaceutical composition
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
JP2574354B2 (ja) * 1986-05-02 1997-01-22 ブリガム・アンド・ウイメンズ・ホスピタル 脂肪酸含有成分およびサイクロスポリンよりなる腎毒性の減少した組成物
NL194638C (nl) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
ES2059558T3 (es) * 1987-06-17 1994-11-16 Sandoz Ag Ciclosporins y su uso como productos farmaceuticos.
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine

Also Published As

Publication number Publication date
AU4941493A (en) 1994-03-29
SK277092A3 (en) 1996-08-07
WO1994005312A1 (en) 1994-03-17
HU9500668D0 (en) 1995-04-28
LV11885B (en) 1998-03-20
DE69309078D1 (de) 1997-04-24
CA2142452C (en) 2001-06-05
JPH08501088A (ja) 1996-02-06
HU221815B1 (hu) 2003-01-28
KR950702840A (ko) 1995-08-23
CZ277092A3 (en) 1994-04-13
KR100294569B1 (ko) 2001-09-17
US5670478A (en) 1997-09-23
HUT75681A (en) 1997-05-28
EP0659084A1 (de) 1995-06-28
EP0659084B1 (de) 1997-03-19
LV11885A (lv) 1997-12-20
CZ278863B6 (en) 1994-07-13
SK278290B6 (en) 1996-08-07
DK0659084T3 (da) 1997-05-05
DE69309078T2 (de) 1997-09-11
ES2102052T3 (es) 1997-07-16
GR3023726T3 (en) 1997-09-30
CA2142452A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
DE69309078D1 (de) N-methylierte zyklische undecapeptide enthaltende arzneimittelzubereitungen
MY145753A (en) Novel cyclosporin analog formulations
DE19975052I2 (de) LHRH Antagonisten, deren Herstellung und entsprechende pharmazeutische Zubereitungen.
NO307205B1 (no) Preparater basert på virkestoffer fra taxanklassen samt perfusjonspreparater inneholdende disse
HUP0300836A2 (hu) Taxánokat tartalmazó szájon át beadható gyógyszerkészítmények és ezek alkalmazása
KR960703015A (ko) 후천성 면역결핍증 치료용 약물의 제조시 노나- 및 데카펩타이드의 용도(Use of nona-and decapeptides in the preparation of a durg for the treatment of AIDS)
MXPA03007942A (es) Preparaciones de insulina exentas de zinc y con bajo contenido de zinc, que tienen una estabilidad mejorada.
MX9406552A (es) Metodo, composiciones y dispositivos para la admi nistracion de polinucleotidos desnudos que codifi can peptidos biologicamente activos.
ES2176204T3 (es) Antidepresivos que contienen un derivado de xantina.
DE69520668D1 (de) Antimikrobielle zubereitungen mit breitem spektrum und verfahren zu ihrer nutzung
GEP20032995B (en) 1-Amino-Alkylcyclohexane NMDA Receptor Antagonists
HUP0000589A2 (hu) Vizes peptid készítmények
NO974270L (no) Insulinderivater
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
HUP0001293A1 (hu) Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
DE69521693T2 (de) Taxanderivate enthaltende arzneizubereitungen
DE69322872T2 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
ES2133295T3 (es) Peptidos ciclicos y su uso.
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
FI956050A (fi) Biologisesti aktiiviset vasopressiinianalogit
ES8602617A1 (es) Un procedimiento para la produccion de peptidos.
DE69630583D1 (de) Peptide, bronchodilator und den blutstrom verbesserndes mittel
HUP9901303A2 (hu) Gyógyszerkészítmény autoimmun betegségek kezelésére

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee